LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Sports Medicine/High Rate of Misreporting in Pediatric Orthopedic Literature
Sports Medicine

High Rate of Misreporting in Pediatric Orthopedic Literature

December 16, 2019 3 min read Premium comments

Advertisement

High Rate of Misreporting in Pediatric Orthopedic Literature
Source: Wikimedia Commons and Alex Proimos
Secondary#pediatricorthopetics#levelofevidence

A new multicenter study led by Hospital for Special Surgery (HSS) has found that the pediatric literature has a depressingly high rate of misreporting.

The study, “How Often Are Study Design and Level of Evidence Misreported in the Pediatric Orthopaedic Literature?,” appears in the November 22, 2019 edition of the Journal of Pediatric Orthopaedics.

Drake LeBrun, M.D., M.P.H., a second year orthopedic surgery resident at Hospital for Special Surgery and co-author on the work explained the genesis of this study to OTW, “In our routine review of the literature, we were noticing high rates of study design misclassification across journals and subspecialties. Such ‘misreporting’ can lead to erroneous interpretations of a study’s findings, which can in turn lead to poor clinical judgments.”

“Once we realized the potential extent of the problem of study design misclassification, we came up with the current study as a way to more systematically assess the degree of study misclassification in a large sample of the orthopaedic literature.”

“First, the majority (52%) of studies simply did not report a clear study design. This makes it challenging for orthopaedic clinicians to understand how the study was conducted, what types of conclusions can be drawn from the data, and what types of bias might affect the results.”

“Secondly, nearly half (48%) of studies in our sample did not report a level of evidence [LoE]. Level of evidence is a helpful—albeit limited—metric of a study’s relative strength. Not reporting a level of evidence has a couple implications.”

“It makes it harder for orthopaedic surgeons to evaluate the strength of the data they are using to make clinical decisions. It also makes it harder for researchers conducting systematic reviews and meta-analyses to synthesize the data in the context of the overall literature.”

“In an era in which meta-analyses allow us to synthesize multiple data sets into broader samples and more rigorous data, it is imperative that the raw data be as clearly and accurately described as possible.”

Advertisement

“Thirdly, among the studies that did report a study design and/or level of evidence, 19% reported the wrong study design and 28% reported the wrong level of evidence. Interestingly, of the studies that misreported their level of evidence, only 35% overreported their level of evidence while 65% underreported (i.e., effectively ‘underselling’) their level of evidence.”

“A few steps could be taken to reduce the rate of study design and level of evidence non-reporting and misreporting. First, it would be helpful if all published observational studies explicitly reported study design and level of evidence according to standardized criteria (e.g., STROBE [Strengthening the Reporting of Observational studies in Epidemiology] criteria, JBJS [Journal of Bone and Joint Surgery] level of evidence guidelines, etc.). Similarly, training reviewers and editors to cross-check a paper’s stated study design and level of evidence would help to ensure that published studies are correctly classified.”

“The use of vague or contradictory terminology should be discouraged. Terms like ‘comparative study,’ ‘retrospective review,’ or ‘chart review’ are vague and not part of standardized epidemiological jargon. These terms could refer to any number of observational study designs and should be discouraged in favor of standardized study designs (e.g., case-control study, retrospective cohort study, etc.) that are consistent throughout the medical literature.”

“Lastly, I’d argue that the differences between observational study designs are relatively straightforward. Orthopaedic investigators should have little difficulty understanding these differences if they were appropriately trained to do so. To that end, it’d be helpful to include a critique of study design and LOE in standard journal clubs and other research-oriented reviews among orthopaedic residents.”

“We would like orthopaedic surgeons to critically evaluate the literature based on an accurate understanding of different observational study designs, and what each type of study design allows one to conclude. Overall, more rigor in evaluating observational studies is required on the part of orthopaedic investigators, reviewers, and journal editors to ensure that the data we use to make clinical decisions is valid and clear.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy